| Price | 7.75p on 10-04-2025 at 18:35:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 8.00p |
| Sell | 7.50p |
| Buy / Sell AGL Shares | |
| Last Trade: | Unknown 162,385.00 at 7.75p |
| Day's Volume: | 1,492,961 |
| Last Close: | 7.75p |
| Open: | 7.75p |
| ISIN: | GB0034330679 |
| Day's Range | 7.75p - 8.25p |
| 52wk Range: | 7.25p - 24.50p |
| Market Capitalisation: | £25m |
| VWAP: | 8.041296p |
| Shares in Issue: | 323m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Angle (AGL) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 162,385 | 7.75p | OTC Trade |
17:06:47 - 10-Apr-25 |
| Sell* | 6,060 | 7.50p | Ordinary |
16:15:06 - 10-Apr-25 |
| Sell* | 18,000 | 7.65p | Ordinary |
15:44:06 - 10-Apr-25 |
| Sell* | 903 | 7.65p | Ordinary |
15:43:34 - 10-Apr-25 |
| Buy* | 63,216 | 7.8999p | Ordinary |
15:21:18 - 10-Apr-25 |
| Sell* | 3,846 | 7.675p | Ordinary |
13:43:21 - 10-Apr-25 |
| Sell* | 49,500 | 8.00p | Ordinary |
13:22:34 - 10-Apr-25 |
| Sell* | 99,000 | 8.00p | Ordinary |
13:12:48 - 10-Apr-25 |
| Sell* | 40,000 | 8.0158p | Ordinary |
12:59:32 - 10-Apr-25 |
| Sell* | 21,923 | 8.0158p | Ordinary |
12:54:50 - 10-Apr-25 |
Angle (AGL) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 21st Mar 2025 7:00 am | RNS | Issue of LTIP Options and Share Options |
| 21st Mar 2025 7:00 am | RNS | Results of Eisai Phase 2 pilot study |
| 6th Feb 2025 7:00 am | RNS-R | Novel findings using Parsortix |
| 29th Jan 2025 7:00 am | RNS | Analysis of CTC-DNA and ctDNA using Illumina assay |
| 24th Jan 2025 10:05 am | RNS-R | Parsortix used in research paper from ETH Zurich |
| 23rd Jan 2025 7:00 am | RNS | Trading Update |
| 26th Sep 2024 7:00 am | RNS | Half-year Report |
| 23rd Sep 2024 7:00 am | RNS | Exclusive agreement for DNA NGS panel |
| 17th Sep 2024 7:00 am | RNS | Notice of Interim Results and Webcast |
| 18th Jul 2024 10:08 am | RNS | Standard form for notification of major holdings |
